|Articles|October 1, 1999

October 1999
Volume 5
Issue 10

Diabetes Managed Care and Clinical Outcomes: The Harbor City, California Kaiser Permanente Diabetes Care System

Download PDF: Diabetes Managed Care and Clinical Outcomes: The Harbor City, California Kaiser Permanente Diabetes Care System

Articles in this issue

over 26 years ago

Article

A Call to Arms for Managed Care

over 26 years ago

Article

Experiences of Ethnic Minority Primary Care Physicians with Managed Care: A National Survey

over 26 years ago

Article

Enhanced Emergency Department Referral Improves Primary Care Access

over 26 years ago

Article

The Effect of Primary Care Gatekeepers on the Management of Patients with Chest Pain

over 26 years ago

Article

Healthcare Utilization Associated with Dyspepsia in Patients with Arthritis

over 26 years ago

Article

Understanding, Creating, and Working with Formulary Systems

over 26 years ago

Article

Equal Employment Opportunity in Managed Care Organizations

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

Diabetes Managed Care and Clinical Outcomes: The Harbor City, California Kaiser Permanente Diabetes Care System

Articles in this issue

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Trending on AJMC

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

Childhood Influenza Vaccine Rates Decreased From 2017 to 2023

Oral Orforglipron Added to Basal Insulin Cuts HbA1c in Type 2 Diabetes